Company Overview
Sales
95.6
Cr
Growth: 21.8%
Profit after Tax
4.01
Cr
Growth:
29.6%
Unknown Cap
N/A
Cr
P/S:
N/A
Industry P/S: 3.3x
Fundamentals
| Sales (Cr) |
₹ 95.6 |
| Growth |
21.8% |
| EBITDA |
9.7% |
| P/S |
N/A |
| Dividend |
0.0% |
| P/E |
N/A |
| Book Value |
₹ 42.3 |
| PEG Ratio |
N/A |
| ROE |
19.1% |
| P/B |
N/A |
Shareholding Pattern
Increase
Decrease
No change
The company specializes in the production of high-quality pharmaceutical products on a loan license or contract manufacturing basis. It has a diverse product portfolio that includes a wide range of pharmaceuticals, nutraceuticals, and food products. Key Events/Milestone/ Achievement2015: The company was incorporated as a private limited company under the name Sotac Pharmaceuticals Private Limited.
